ApprovalTrail

Drug · DIN 02329867 · Radiopharmaceutical

CEA-SCAN

No: cancelled before it was sold

Authorized, then cancelled before it was ever sold in Canada.

Status Cancelled Pre Market since September 6, 2022.
Drug Identification Number (DIN)
02329867
Company (DIN owner)
Immunomedics, Inc.Morris Plains, New Jersey, United States
Schedule
Schedule C
Dosage form
Powder For Solution
Route
Intravenous; Intravascular
Class
Radiopharmaceutical
Record last updated
March 22, 2025

Active ingredients

As listed in the Drug Product Database.

IngredientStrengthPer
ARCITUMOMAB1.25 MGVIAL